Skip to Main Content

Paper Details

Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: A multi-center, single-arm, phase 2 study.
Cancer Med
4
2023
Author NameAffiliation
Rong FanPeking Union Medical College Hospital
  • 1 - 1

Datasets

Release 1.2